More news
- Nigeria’s paint industry navigates regulatory changes and economic challenges amid p...
- Focus on the global coatings market: Global coatings market outlook
- Ask Joe Powder – October 2024
- Chinese paint majors look to domestic consumer sales as commercial real estate slumps
- Architectural coatings in Nepal and Bhutan
Kansai Paint Group has gained approval from the USA Environmental Protection Agency (EPA) for its Kansai Anti-Mosquito Paint.
The Kansai Anti-Mosquito Paint is designed for interior use and contains a synthetic pyrethroid insecticide.
The paint has been shown to significantly reduce the presence of mosquitoes in painted areas, contributing to effective mosquito population control and reducing the spread of many mosquito-borne diseases.
Formulas for all base colours have been approved for use in this product, enabling Kansai to offer a wide range of attractive colours.
"Development of the Kansai Anti-Mosquito Paint marks a major milestone, not only for our company but also for the worldwide effort in fighting the spread of infectious diseases,” said Hiroshi Ishino.
"For generations, people all over the world have struggled with mosquito-borne illnesses and the effects they have on families and communities.
"Kansai is proud to be the first company in the world to develop a safe paint, approved by the EPA that addresses this challenge in a creative and effective way.”
Kansai Paint Group began development of the Kansai Anti-Mosquito Paint in 2013.
After several years of extensive testing, the application was officially submitted to the EPA in early 2017.
Approval was secured in just over 12 months, marking a near-record authorisation time for products in this industry.
The Kansai Anti-Mosquito Paint is the only anti-mosquito paint that is approved by the EPA.
It is currently approved in Uganda and Zambia and is expected to be available in the USA by summer of 2018.
Contact with the active ingredient in Kansai Anti-Mosquito Paint disables the nervous systems of mosquitos and prevents them from flying and biting.
Use of the active ingredient in this product has not shown to be dangerous for humans, either by physical contact or oral ingestion.
Further, presence of the active ingredient does not affect the paint’s aesthetic quality, as the Kansai Anti-Mosquito Paint provides a smooth, matte finish with superior opacity and whiteness.
"Our testing has showed that the Kansai Anti-Mosquito Paint was able to exterminate on contact more than 90% of mosquitoes and is effective for at least two years,” noted Kalpana Abe, Vice President, President’s Office, Kansai Paint Group.
"It will deter various species of mosquitos, which can carry several viruses present in the USA, including Zika and the West Nile.”
Production of the Kansai Anti-Mosquito Paint in the USA will be led by U.S. Paint, a subsidiary of the Kansai Paint Group, acquired in 2016.
While the product has been available for limited sale around the world, approval from the EPA marks a significant advancement in the company’s ability to compete in the USA market.
EPA approval is also expected to hasten approvals abroad.